Atrasentan shows positive interim results in IgA nephropathy: ALIGN phase 3 trial Presented ByProf. Hiddo J.L. Heerspink, University Medical Center Groningen, The Netherlands TrialPhase 3, ALIGN ConferenceERA 2024 TypeNews article 20 June 2024 19:05